Xenon Pharmaceuticals Inc.

By person

23 insiders · 217 transactions

2.6×

Ian Mortimer holds only 2.6 times base salary in stock. $2.09M of shares against $786.00K in salary for 2025.

Salary from the company's own proxy. The shares are what Ian Mortimer last reported holding, valued at $60.98, the price Common Shares was last bought or sold at on the open market here, on 28 Aug 2026.

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

MORTIMER IAN

PRESIDENT & CEO

$43.23K (2)

$24.82M (25) scheduled

−$24.78M

34,223

0.0353%

$2.09M

+545.7%

PIMSTONE SIMON N.

Director

$17.40K (1)

$14.96M (34)

−$14.95M

6,000

0.0062%

$365.86K

−97.2%

EMPFIELD JAMES R.

EVP, Drug Discovery

$24.82K (1)

$3.78M (5) scheduled

−$3.75M

10,000

0.0103%

$609.77K

—

ROBIN SHERRINGTON

EVP, Strategy & Innovation

—

$3.61M (11) scheduled

−$3.61M

8,398

0.0087%

$512.08K

+108.8%

BVF PARTNERS L P/IL entity

10% owner

$2.05M (28)

—

+$2.05M

59,464

0.0614%

$3.63M

−96.9%

AULIN SHERRY

Chief Financial Officer

—

$1.38M (3) scheduled

−$1.38M

0.0000%

$0.00

—

GANNON STEVEN

Director

$42.27K (1)

$1.24M (6)

−$1.20M

1,870

0.0019%

$114.03K

—

PATOU GARY

Director

$35.84K (2)

$1.17M (9) scheduled

−$1.13M

29,798

0.0308%

$1.82M

+647.6%

Svoronos Dawn

Director

$140.77K (1)

$967.50K (1)

−$826.73K

31,373

0.0324%

$1.91M

—

KENNEY CHRISTOPHER JOHN

Chief Medical Officer

$20.17K (1)

$694.76K (5) scheduled

−$674.60K

<0.0001%

$121.95

+100.0%

HOLLER FRANK A

Director

—

$649.32K (7)

−$649.32K

143,653

0.1483%

$8.76M

−1.5%

DiFabio Andrea

Chief Legal Officer

—

$230.81K (2) scheduled

−$230.81K

7,301

0.0075%

$445.19K

—

Von Seggern Christopher

Chief Commercial Officer

$97.60K (1)

—

+$97.60K

4,000

0.0041%

$243.91K

—

GAROFALO ELIZABETH A.

Director

—

$95.58K (1) scheduled

−$95.58K

2,645

0.0027%

$161.28K

—

AZAB MOHAMMAD

Director

$81.14K (5)

$214.18 (1)

+$80.93K

74,225

0.0766%

$4.53M

+1,403%

Cannon Gillian

Director

—

$63.24K (1) scheduled

−$63.24K

1,455

0.0015%

$88.72K

—

Hayden Michael R

Director

$41.25K (1)

—

+$41.25K

208,282

0.2151%

$12.70M

+169.4%

SCHELLER RICHARD H

Director

$19.95K (1)

—

+$19.95K

7,000

0.0072%

$426.84K

—

WINQUIST RAYMOND

Head, Translational Research

$3.00K (1)

—

+$3.00K

1,000

0.0010%

$60.98K

—

TARNOW MICHAEL M

Director

—

77,942

0.0805%

$4.75M

+41.3%

COHEN CHARLES J.

VP, Biology

—

6,550

0.0068%

$399.40K

—

Machado Patrick

Director

—

2,645

0.0027%

$161.28K

—

Gover Justin D.

Director

—

2,645

0.0027%

$161.28K

—

Individual transactions

Insider

Date

Role

Action

Price

Amount

Svoronos Dawn

1 Sep 2026

Director

Exercised, kept

5,144

$8.15

$41.92K

GANNON STEVEN

12 May 2026

Director

Exercised, kept

3,500

$7.38

$25.83K

GANNON STEVEN

14 May 2025

Director

Exercised, kept

5,144

$12.57

$64.66K

AZAB MOHAMMAD

19 Dec 2023

Director

Exercised, kept

3,497

$9.85

$34.45K

AZAB MOHAMMAD

19 Dec 2023

Director

Exercised, kept

823

$9.85

$8.11K

AZAB MOHAMMAD

12 Dec 2022

Director

Exercised, kept

3,086

$2.68

$8.27K

AZAB MOHAMMAD

15 Dec 2021

Director

Exercised, kept

3,086

$3.67

$11.33K

PATOU GARY

8 Dec 2021

Director

Exercised, kept

2,057

$3.67

$7.55K

PIMSTONE SIMON N.

24 May 2021

CEO

Exercised, kept

22,633

$3.76

$85.10K

Hayden Michael R

18 May 2021

Director

Exercised, kept

3,500

$3.85

$13.48K

TARNOW MICHAEL M

18 May 2021

Director

Exercised, kept

5,144

$3.67

$18.88K

TARNOW MICHAEL M

18 May 2021

Director

Exercised, kept

1,028

$3.67

$3.77K

TARNOW MICHAEL M

18 May 2021

Director

Exercised, kept

2,057

$3.87

$7.96K

Hayden Michael R

18 Feb 2021

Director

Exercised, kept indirect

30,864

$2.68

$82.72K

Hayden Michael R

18 Feb 2021

Director

Exercised, kept indirect

10,288

$3.67

$37.76K

Hayden Michael R

16 Feb 2021

Director

Exercised, kept

5,144

$2.68

$13.79K

AZAB MOHAMMAD

15 Dec 2020

Director

Exercised, kept

3,086

$3.76

$11.60K

PATOU GARY

28 Oct 2020

Director

Exercised, kept

2,057

$3.76

$7.73K

TARNOW MICHAEL M

28 Oct 2020

Director

Exercised, kept

5,144

$3.76

$19.34K

TARNOW MICHAEL M

28 Oct 2020

Director

Exercised, kept

5,144

$3.76

$19.34K

TARNOW MICHAEL M

9 Jun 2020

Director

Exercised, kept

5,144

$3.52

$18.11K

ROBIN SHERRINGTON

1 Jun 2020

EVP, Strategy & Innovation

Exercised, kept

8,230

$3.56

$29.30K

HOLLER FRANK A

29 May 2020

Director

Exercised, kept

3,086

$3.56

$10.99K

PIMSTONE SIMON N.

26 May 2020

CEO

Exercised, kept

6,172

$3.56

$21.97K

AZAB MOHAMMAD

16 Dec 2019

Director

Exercised, kept

3,086

$3.56

$10.99K

PATOU GARY

4 Dec 2019

Director

Exercised, kept

2,057

$3.56

$7.32K

TARNOW MICHAEL M

21 Nov 2019

Director

Exercised, kept

2,057

$3.51

$7.22K

TARNOW MICHAEL M

21 Nov 2019

Director

Exercised, kept

5,144

$3.56

$18.31K

PIMSTONE SIMON N.

17 Sep 2019

CEO

Exercised, kept

12,345

$3.38

$41.73K

PIMSTONE SIMON N.

17 Sep 2019

CEO

Exercised, kept

9,259

$3.07

$28.43K

PIMSTONE SIMON N.

17 Sep 2019

CEO

Exercised, kept

36,008

$3.70

$133.23K

ROBIN SHERRINGTON

12 Sep 2019

EVP, Strategy & Innovation

Exercised, kept

6,172

$3.07

$18.95K

HOLLER FRANK A

12 Sep 2019

Director

Exercised, kept

25,720

$3.00

$77.16K

HOLLER FRANK A

12 Sep 2019

Director

Exercised, kept

3,086

$3.07

$9.47K

HOLLER FRANK A

12 Sep 2019

Director

Exercised, kept

3,086

$3.70

$11.42K

TARNOW MICHAEL M

21 May 2019

Director

Exercised, kept

2,057

$3.21

$6.60K

Hayden Michael R

19 Mar 2019

Director

Exercised, kept indirect

20,576

$3.38

$69.55K

PATOU GARY

14 Dec 2018

Director

Exercised, kept

2,057

$3.07

$6.31K

COHEN CHARLES J.

11 Dec 2018

VP, Biology

Exercised, kept

4,115

$3.07

$12.63K

AZAB MOHAMMAD

6 Dec 2018

Director

Exercised, kept

3,086

$3.07

$9.47K

AZAB MOHAMMAD

21 Jun 2018

Director

Exercised, kept

10,288

$3.70

$38.07K

TARNOW MICHAEL M

21 Jun 2018

Director

Exercised, kept

5,144

$3.07

$15.79K

TARNOW MICHAEL M

21 Jun 2018

Director

Exercised, kept

2,057

$3.66

$7.53K

TARNOW MICHAEL M

21 Jun 2018

Director

Exercised, kept

5,144

$3.70

$19.03K

PATOU GARY

14 Jun 2018

Director

Exercised, kept

8,230

$3.70

$30.45K

ROBIN SHERRINGTON

15 Mar 2018

EVP Bus. & Corp. Development

Exercised, kept

3,086

$3.77

$11.63K

HOLLER FRANK A

14 Mar 2018

Director

Exercised, kept

3,086

$3.77

$11.63K

PIMSTONE SIMON N.

12 Mar 2018

CEO

Exercised, kept

10,288

$3.77

$38.79K

COHEN CHARLES J.

12 Feb 2018

VP, Biology

Exercised, kept

26,748

$3.71

$99.24K

TARNOW MICHAEL M

19 Jun 2017

Director

Exercised, kept

1,028

$3.51

$3.61K

ROBIN SHERRINGTON

12 May 2017

SVP Bus. & Corp. Development

Exercised, kept

2,057

$3.21

$6.60K

Hayden Michael R

14 Mar 2017

Director

Exercised, kept indirect

3,086

$3.56

$10.99K

Hayden Michael R

14 Mar 2017

Director

Exercised, kept indirect

4,629

$3.07

$14.21K

Hayden Michael R

14 Mar 2017

Director

Exercised, kept indirect

4,115

$3.77

$15.51K

Hayden Michael R

14 Mar 2017

Director

Exercised, kept

5,144

$3.67

$18.88K

Hayden Michael R

14 Mar 2017

Director

Exercised, kept

25,720

$3.76

$96.71K

Hayden Michael R

14 Mar 2017

Director

Exercised, kept

18,004

$3.70

$66.61K

TARNOW MICHAEL M

12 Dec 2016

Director

Exercised, kept

14,403

$3.21

$46.23K

PATOU GARY

6 Dec 2016

Director

Exercised, kept

12,345

$3.21

$39.63K

AZAB MOHAMMAD

1 Dec 2016

Director

Exercised, kept

12,345

$3.21

$39.63K

Show all 217 transactions →

Xenon Pharmaceuticals Inc.

By person

Individual transactions

What was left out